Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study
Authors
Chongqi Sun (ORCID: https://orcid.org/0009-0000-7018-793X)
Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study
Chongqi Sun, Tongpeng Xu, Xiangrong Zuo, Ling Zhu et al.
Citations
10 citations
Journal
Genome Medicine
Topics
CAR-T cell therapy research
Field-Weighted Citation Impact (FWCI)
2.83
article
Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study
Nanjing University of Chinese Medicine (CN), Suzhou Municipal Hospital (CN), Jiangsu Province Hospital (CN), Wuxi People's Hospital (CN), Nano Carbon (Poland) (PL), Nanjing Medical University (CN)
Funders
National Natural Science Foundation of China, Government of Jiangsu Province, Natural Science Foundation of Jiangsu Province, Nanjing Medical University
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Efficacy and safety of novel multiple-chain DAP-CAR-T cells targeting mesothelin in ovarian cancer and mesothelioma: a single-arm, open-label and first-in-human study — Chongqi Sun, Tongpeng Xu, et al. · Genome Medicine (2024) | TGRS Research Map | TGRS